Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014
Filters: Author is Montefiori, David C [Clear All Filters]
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies.. Journal of virology. 88(5):2489-507.. 2014.
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines.. Nature medicine. 18(11):1673-81.. 2012.
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.. The Journal of infectious diseases. 202(4):595-605.. 2010.
Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors.. Journal of virology. 83(17):8925-37.. 2009.
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine.. The New England journal of medicine.. 2013.
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.. The New England journal of medicine. 366(14):1275-86.. 2012.
Simultaneous Evaluation of the Magnitude and Breadth of a Left and Right Censored Multivariate Response, with Application to HIV Vaccine Development.. Statistics in biopharmaceutical research. 1(1):81-91.. 2009.
A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling.. Journal of immunological methods.. 2013.
Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials.. Vaccine. 33(20):2347-53.. 2015.
The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120.. AIDS research and human retroviruses. 28(11):1444-57.. 2012.
Improving neutralization potency and breadth by combining broadly reactive HIV-1 antibodies targeting major neutralization epitopes.. Journal of virology. 89(5):2659-71.. 2015.
Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.. Science translational medicine. 3(81):81ra36.. 2011.
Infectious Virion Capture by HIV-1 gp120 Specific IgG from RV144 Vaccinees.. Journal of virology.. 2013.
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials.. The Journal of infectious diseases. 206(3):431-41.. 2012.
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 79(8):603-12.. 2011.
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.. Journal of virology. 84(3):1439-52.. 2010.
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.. Journal of immunological methods. 375(1-2):57-67.. 2012.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- Information for Grant Writers
- Arnold Library News
- Affiliations and Memberships
- Journals List
- Web of Science - Science Citation Index
- Pubmed (Get Article Enabled)
- Library Catalog
- Document Delivery Form
- Center-Authored Papers
- Institutional Repository
- Researcher Profiles